- Home
- OCEAW vs CB Comparison
OCEAW vs CB Comparison
Compare OCEAW & CB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCEAW
- CB
- Stock Information
- Founded
- OCEAW N/A
- CB 1985
- Country
- OCEAW United States
- CB Switzerland
- Employees
- OCEAW 7
- CB N/A
- Industry
- OCEAW Biotechnology: Pharmaceutical Preparations
- CB Property-Casualty Insurers
- Sector
- OCEAW Health Care
- CB Finance
- Exchange
- OCEAW Nasdaq
- CB Nasdaq
- Market Cap
- OCEAW N/A
- CB 114.8B
- IPO Year
- OCEAW 2021
- CB 1993
- Fundamental
- Price
- OCEAW $0.03
- CB $288.57
- Analyst Decision
- OCEAW
- CB Buy
- Analyst Count
- OCEAW 0
- CB 17
- Target Price
- OCEAW N/A
- CB $299.50
- AVG Volume (30 Days)
- OCEAW N/A
- CB 1.8M
- Earning Date
- OCEAW N/A
- CB 04-22-2025
- Dividend Yield
- OCEAW N/A
- CB 1.26%
- EPS Growth
- OCEAW N/A
- CB 4.13
- EPS
- OCEAW N/A
- CB 22.70
- Revenue
- OCEAW N/A
- CB $55,882,000,000.00
- Revenue This Year
- OCEAW N/A
- CB N/A
- Revenue Next Year
- OCEAW N/A
- CB $5.52
- P/E Ratio
- OCEAW N/A
- CB $12.71
- Revenue Growth
- OCEAW N/A
- CB 12.45
- 52 Week Low
- OCEAW N/A
- CB $238.85
- 52 Week High
- OCEAW N/A
- CB $302.05
- Technical
- Relative Strength Index (RSI)
- OCEAW N/A
- CB 59.73
- Support Level
- OCEAW N/A
- CB $280.40
- Resistance Level
- OCEAW N/A
- CB $295.73
- Average True Range (ATR)
- OCEAW 0.00
- CB 6.19
- MACD
- OCEAW 0.00
- CB 0.81
- Stochastic Oscillator
- OCEAW 0.00
- CB 73.65
About OCEAW Ocean Biomediacal Inc.
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.
About CB Chubb Limited
ACE acquired Chubb in the first quarter of 2016 and assumed the Chubb name. The combination made the new Chubb one of the largest domestic property and casualty insurers, with operations in 54 countries spanning commercial and personal P&C insurance, reinsurance, and life insurance.